Patarroyo J, Genç A, Arbiol J, Bastús NG, Puntes V. Chem Commun (Camb). 2016 Sep 21;52(73):10960-3. https://www.ncbi.nlm.nih.gov/pubmed/?term=27498830 Abstract Green silver nanorods (Ag NRs) of a low aspect ratio (2.8) have been produced in high...
Read morePreclinical Services
Asdent donates more than 120,000 euros to raise funds for the Dent’s disease at Vall d’Hebron
Nacho is a 6-year-old child who was diagnosed when he was 3 with the Dent’s disease; a rare untreatable disease which may result in renal failure. Since the diagnosis, his parents have not stop to reverse this situation getting researchers...
Read moreCharacterization of the Biodistribution and Systemic Absorption of TT-173, a New Hemostatic Agent of Recombinant Human Tissue Factor, Using Radiolabeling with 18F.
Rojas S, Herance JR, Gispert JD, Arias B, Miquel I, López R, Sánchez P, Rincón E, Murat J Eur J Drug Metab Pharmacokinet. 2016 Aug 22. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/?term=27550654 Abstract BACKGROUND AND...
Read moreDr. Simó Schwartz, Scientific, appointed president of the European Society for Nanomedicine (ESNAM)
The objectives of ESNAM are to promote nanomedicine research and facilitate the exchange of knowledge among its members (currently, about 800 members). According to Dr. Simó Schwartz “the dissemination of specialized infrastructure in...
Read moreVHIR brings nanomedicine to the Science Festival
The Vall d’Hebron Research Institute (VHIR) participated once again in the Science Festival, which this year has reached its 10th edition. Dr. Víctor Puntes, head of the group of Design and Pharmacodynamics of Nanoparticles, gave a talk...
Read moreVHIR presented the results of three projects of the TV3’s Marathon 2010
On Wednesday 15 June was held the Symposium on acquired spinal cord and brain injuries, in which have been presented the results of the 30 projects funded in the 2010 edition of the TV3 Marathon. Of these projects, three were carried out at the...
Read moreThe Association for Familial Hypomagnesemia donates once again 15000 € for the research of this disease
For the second year in a row, the Association for Information and Research of Familial Hipomagnesemia (Hipofam) has given 15000 euros to the research group on Renal Physiopathology of Vall d’hebron Research Institute (VHIR) to investigate...
Read moreDr. Schwartz Jr participates in a European nanomedicine project for pancreatic cancer
The Drug Delivery and Targeting group from the CIBBIM-Nanomedicine at VHIR, led by Dr. Simó Schwartz Jr., participates in a new European project, called NoCanTher, which aims to develop treatments with nanomedicine for pancreatic ductal...
Read moreConformational and functional variants of CD44-targeted protein nanoparticles bio-produced in bacteria
Pesarrodona M1, Fernández Y, Foradada L, Sánchez-Chardi A, Conchillo-Solé O, Unzueta U, Xu Z, Roldán M, Villegas S, Ferrer-Miralles N, Schwartz S Jr, Rinas U, Daura X, Abasolo I, Vázquez E, Villaverde A. Biofabrication. 2016 Apr 14;8(2):025001...
Read moreAlpha-Galactosidase A Loaded Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration.
I Cabrera, I Abasolo, JL.Corchero, E Elizondo, P Rivera Gil, E Moreno, J Faraudo, S Sala, D Bueno, E González-Mira, M Rivas, M Melgarejo, D Pulido, F Albericio, M Royo, A Villaverde, M F. García-Parajo, Schwartz S Jr., N Ventosa, J Veciana...
Read moreDr. Anna Meseguer receives grant from the American Association for Cancer Research
Dr. Anna Meseguer, head of the Kidney Physiopathology group at the Vall d’Hebron Institute of Research (VHIR), has received the 2016 Research Grant for Immunotherapy in Kidney Cancer of the American Association for Cancer Research, endowed with...
Read more